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Ultrastructural morphology and expression of
proteoglycans, âig-h3, tenascin-C, fibrillin-1, and
fibronectin in bullous keratopathy
Saeed Akhtar, Anthony J Bron, Nicholas R Hawksworth, Richard E Bonshek,Keith M Meek
Abstract
Aims—To investigate the ultrastructural
localisation of proteoglycans (PG), âig-h3
(keratoepithelin), tenascin-C (TN-C)), fi-
brillin, and fibronectin in bullous kerat-
opathy (BK) corneas.
Methods—Five corneas from cases of
pseudophakic bullous keratopathy (BK)
were examined by electron microscopy.
PG were demonstrated using cuprolinic
blue, and the proteins âig-h3, TN-C,
fibrillin, and fibronectin were immunolo-
calised with rabbit anti-âig-h3, mouse
anti–TN-C (BC10 and TN2), mouse anti-
fibrillin-1 (MAB2502), mouse anti-
fibrillin (MAB1919), and rabbit anti-
fibronectin by using a standard
immunogold technique.
Results—Epithelial cells contained numer-
ous vacuoles. Epithelial folds and large,
electron lucent subepithelial bullae were
present. Basal lamina was thickened and
traversed by disrupted anchoring fila-
ments. In the stroma, interfibrillar colla-
gen spacing was increased and abnormally
large PG were present. Descemet’s mem-
brane (DM) contained lucent spaces in
which there were small filaments. Kerato-
cyte and endothelial cells contained mela-
nin granules. A posterior collagenous layer
(PCL) contained numerous microfila-
ments and wide spacing collagen fibres
with a periodicity of 100 nm. Large quanti-
ties of abnormal PG were observed at the
endothelial face of the PCL. Very strong
labelling with âig-h3 antibody was ob-
served in the basement membrane, Bow-
man’s layer, stroma,DM, and PCL, but not
in keratocytes and endothelial cells. Strong
labelling with BC10 and TN2 was seen
below the epithelium, in electron lucent
spaces where the hemidesmosomes were
absent, in the fibrotic pannus, in parts of
Bowman’s layer, the stroma, and De-
scemet’s membrane. Labelling with BC10
was stronger and more evenly distributed
than with TN2. Fibrillin-1 (MAB2502) and
fibrillin (MAB1919) labelling was similar to
TN-C labelling. Fibrillin (MAB1919) label-
ling was stronger than fibrillin-1
(MAB2502) labelling.
Conclusions—Immunoelectron micros-
copy showed precise labelling of proteins
at both the cellular and the subcellular
level. Expression of proteins âig-h3,
TN-C, fibrillin, and fibronectin was highly
increased compared with normal cornea.
In the oedematous stroma, increased
collagen fibril separation may facilitate a
wider distribution of some soluble pro-
teins, such as âig-h3, throughout stroma.
The modified expression of the proteins
studied in these cases of BK may be
regarded as part of an injury response.
(Br J Ophthalmol 2001;85:720–731)
Post-surgical bullous keratopathy is a leading
indication for keratoplasty. Both aphakic and
phakic BK are due to endothelial dysfunction,
giving rise to epithelial bullae and stromal
oedema resulting in loss of transparency.
Ultrastructural changes in BK have been
reported by various authors.1–3 Immunohisto-
chemically, it has been shown that BK is asso-
ciated with the expression of TN-C,4 5 fibro-
nectin, fibrillin,4 6 and âig-h3.7
âig-h3 is an extracellular matrix protein that
was first detected in a human lung adenocarci-
noma cell line after stimulation by TGF-â.8
Recently, specific missense mutations have been
reported in the âig-h3 gene (transforming
growth factor â induced gene) in four autosomal
dominant corneal dystrophies—that is, lattice
type I, granular, Avellino, and Reis-Bückler’s
corneal stromal dystrophies.9 âig-h3 has been
immunohistochemically localised to numerous
body tissues, particularly within the basement
membrane of skin and interstitial tissue.10 11
TN-C is a large hexameric glycoprotein com-
posed of multiple domains.12–14 It is one of a
family of four proteins, tenascin-cytotactin
(TN-C), tenascin-restrictin (TN-R), tenascin-X
(TN-X), and tenascin-Y (TN-Y) derived from
diVerent gene products.14–17 They play an impor-
tant part in many dynamic cellular activities. In
humans, TN-R is restricted to the central nerv-
ous system and TN-Y has been described only
in the chicken.12 14 18 TN-C is the product of a
single gene localised within region q32-q34 of
chromosome 9.19 20 However, alternative mRNA
splicing gives rise to a number of variants which
are associated with the mediation of a wide
range of cellular properties, such as adhesion,
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anti-adhesion, migration, proliferation, and
diVerentiation.21–23 TN-C is expressed in the
human cornea in development, healing and
repair, and inflammation and scarring.24–27 In
addition, a number of studies have documented
expression of TN-C and its variants in bullous
keratopathy.4 5
Fibrillin-1 (FBN1) is a high molecular weight
glycoprotein found in virtually all extracellular
matrices.28–30 Mutation in the FBN1 gene that
encodes fibrillin is responsible for Marfan
syndrome, an autosomal dominant, connective
tissue disorder, that aVects the cardiovascular
and musculoskeletal system, as well as the eye.
In the present paper, we report for the first
time the immunoelectron localisation of the
proteins âig-h3, tenascin-C (clone TN-2 and
BC10), fibrillin-1, and fibronectin with refer-
ence to the detailed ultrastructural morphol-
ogy of bullous keratopathy corneas.
Methods
A normal corneal button was obtained 24
hours post mortem and three BK corneal but-
tons were obtained within 30 minutes of
penetrating keratoplasty and were fixed imme-
diately. Two more buttons were obtained from
archived material (2 years old) by processing
wax blocks through xylene and a graded series
of ethanol (see Table 1).
All the corneas were divided into three parts.
The first part was immersed in 3% glutaralde-
hyde in 0.1M phosphate buVer for 2 hours and
post-fixed in 1% osmium tetroxide in 0.1M
phosphate buVer for a further hour. The
second part was fixed in 3% glutaraldehyde
containing 0.05% cuprolinic blue (BDH Ltd,
Dorset) using a critical electrolyte concentra-
tion mode. The tissue was then dehydrated
through a graded ethanol series and embedded
in Spurr resin. Semithin (1 µm) sections were
stained with toluidine blue for light micros-
copy. Ultrathin sections were stained with ura-
nyl acetate and lead citrate, and observed by
transmission electron microscopy (Jeol 1010;
Jeol Ltd, Akishima, Japan).
The third part (less than 1 mm3) was fixed in
freshly prepared 4% paraformaldehyde (PFA)
in 0.1M phosphate for 2 hours at 4°C. Tissue
was washed three times (15 minutes) in 0.1M
PBS, and dehydrated in 30%, 50% (4°C), and
in 70%–100% ethanol (−20°C) (1 hour in
each). Tissues were infiltrated at −20°C in two
1 hour changes of a mixture of 100% ethanol
and LR white (−20°C) and three 8 hour
changes of LR white (−20°C). They were
finally polymerised in LR white at −20°C for
48 hours under ultraviolet light. Ultrathin sec-
tions were cut from the blocks and collected on
200 mesh formvar-carbon nickel grids.
IMMUNOELECTRON MICROSCOPY
Polyclonal, rabbit, anti-human âig-h3 antibody
was a gift from Dr K Bennett, Bristol Myers
Squibb, USA. The monoclonal antibodies:
mouse anti-human tenascin, BC10, (MAB
1918), mouse anti-human fibrillin-1 (MAB
2502), and mouse anti-human-fibrillin (MAB
1919), were obtained from Chemicon, Inter-
national, UK. Monoclonal mouse anti-human
tenascin, TN2, (MO636) and polyclonal rab-
bit anti-human fibronectin were obtained from
Dako Ltd, UK. The specificity of the antibody
to human antigens was tested and confirmed
by the supplier with immunological assays.
Antibodies were visualised with 10 nm goat
anti-mouse and goat anti-rabbit immunogold
conjugate. The immunogold conjugates, goat
serum, bovine serum, and Tween-20 were sup-
plied by Biocell, CardiV, UK.
Sections were treated at room temperature by
floating on a 50 µl drop of phosphate buVered
saline (PBS) containing 0.1% bovine serum
albumin (PBS-BSA) for 15 minutes, followed
by PBS-BSA containing 5% normal goat serum
for 30 minutes. They were incubated overnight
in primary antibody, rabbit anti-human âig-h3
(1:50 to 1:500), mouse anti-human tenascin,
BC10, (MAB 1918) (1:50 to 1:500), mouse
anti-human tenascin, TN2, (MO636) (1:25),
mouse anti-human fibrillin-1 (MAB 2502),
anti-human fibrillin MAB 1919 (1:50 to 1:500),
and rabbit anti-human fibronectin (1:50). To
remove unbound antibody, sections were
washed with 0.05 M TRIS buVered saline
(TBS) pH 7.4 (three washes, 5 minutes each),
TBS pH 7.4 containing 0.2% BSA (three
washes, 5 minutes each) and TBS pH 8.4
containing 1% BSA for 3 × 5 minutes. Sections
were then incubated in secondary antibody-10
nm immunogold conjugate diluted 1:25 in TBS
pH 8.4 containing 1% BSA for 50 minutes. The
unbound secondary antibody was removed by
washing in TBS-BSA (three washes, 5 minutes
each), PBS, and distilled water (three washes, 5
minutes each). In all experiments, immuno-
chemical controls were performed by substitut-
ing normal goat serum for the primary antibody.
The immunoreaction was repeated three times
with three replicates for each antibody used.
Normal tissue was processed in parallel as a
control. Sections were stained with 2% aqueous
uranyl acetate and lead citrate and examined in
a Jeol 1010 transmission electron microscope.
Results
Ultrastructural findings and immunolocalisa-
tion of proteins in all BK corneas were similar.
EPITHELIUM
Epithelial cells were degenerate and had
numerous large vacuoles, especially around the
nucleus (Fig 1A). There were large lucent
spaces inside most basal epithelial cells, above
Bowman’s layer (Fig 1B), many of which
Table 1 Clinical data of pseudophakic/aphakic bullous keratopathy (PBK/ABK) patients
Specimen
Age
(years) Sex Clinical details Diagnosis
1 61 Female Endothelial decompensation
following cataract extraction
ABK/PBK
2 86 Female Radial iridotomy and
trabeculectomy
BK with
pseudophakia and
pupilloplasty
3 76 Male Anterior chamber lens and
subsequent corneal decompensation
PBK
4 85 Female Anterior chamber lens and
subsequent corneal decompensation
PBK
5 76 Female Anterior chamber lens and
subsequent corneal decompensation
PBK
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coalesced to form extensive subepithelial bul-
lae. Hemidesmosomes were often absent or
degenerate. The subepithelial basal lamina
(1.5–2 µm thick) was thickened, showing a
grid-shaped structure with disrupted anchor-
ing filaments (40–120 nm long) ((Figs 1C, D).
In some places, the subepithelial region was
infiltrated by thick fibrotic tissue (1 µm thick)
containing microfilaments, basement mem-
brane material, and remnants of keratocytes
(Fig 1E), below which was either a normal
looking Bowman’s layer (7 µm) or a degenerate
Bowman’s layer containing rounded electron
dense material.
Small folds of epithelium were present,
which contained basal laminar material with
numerous disrupted anchoring filaments (Fig
2A–C). Occasionally, below an electron dense
basal lamina, degenerate keratocytes lined up
in a single layer within fibrotic tissue (Fig 2A).
The degenerate keratocytes appeared to be
migrating into the base of each fold (Fig 2B).
STROMA
In some regions of the stroma, the separation
of collagen fibrils was greater than normal and
the interfibrillar space contained a network of
very fine filaments. There were electron lucent
lakes throughout the stroma. Wavy collagen
lamellae were prominent in the pre-Descemet’s
stroma and around the pre-Descemet’s spaces
(Fig 2D). Wavy lamellae were also seen in
other parts of stroma. Wide spacing collagen
fibrils were observed just below the epithelium
Figure 1 Electron micrographs showing ultrastructural alteration in a bullous keratopathy cornea. (A) Electron lucent
vacuole (V) in a degenerate basal epithelial cell (E) and vacuoles in the subepithelial region. (B) Subepithelial vacuole (V)
between an epithelial cell (E) and Bowman’s layer (B). (C) Thick basement membrane (BM) between epithelial cells (E)
and Bowman’s layer (B). (D) Basement membrane (BM) containing anchoring filaments (AC) above Bowman’s layer
(B). (E) Subepithelial pannus (P) containing microfilaments (MF) and rounded keratocytes (KR).
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in a degenerate fibrotic pannus and in the pos-
terior stroma. Groups of microfilaments were
seen in some parts of the stroma, especially
adjacent to Descemet’s membrane (DM) (Fig
3C).
DESCEMET’S MEMBRANE AND POSTERIOR
COLLAGENOUS LAYER
Descemet’s membrane (DM) was 8–10 µm
thick and was diVerentiated into banded and
non-banded zones. The non-banded zone had
numerous lucent spaces which contained small
filaments. A prominent banding pattern similar
to banded DM, was occasionally seen in the
middle of the homogeneous DM. In the DM of
all corneas, there were electron lucent cracks or
breaks, scrolls of Descemet’s material, and
nodule formation with the appearance of
Hassal-Henle warts. These contained degener-
ate collagen fibrils (Fig 3A, B). The posterior
collagenous layer (PCL) contained numerous
groups of microfilaments and very prominent
wide spacing fibres with a periodicity of 100
nm (Fig 3C) embedded in basement
membrane-like material. The bands of wide
spacing fibrils were connected by very thin
microfibrils. Collagen fibrils were degenerate
and sparse, and were distributed between
large, lucent spaces. Some endothelial cells
were present on the posterior surface of the
posterior collagenous layer, but in most
regions, no cells were present. Where endothe-
lial cells were observed, the cytoplasm was
dense, with prominent rough endoplasmic
Figure 2 Light and electron micrograph of bullous keratopathy cornea. (A) Epithelial fold containing basement
membrane material (BM).Keratocytes (KR) are arranged in a line above Bowman’s layer (B) and the anterior stroma.
(B) High magnification of the epithelial fold shown in (A). Keratocytes (KR) are present in the epithelial fold which
contains basement membrane material (BM). (C) Part of an epithelial fold showing disrupted anchoring filaments (AC)
in basement membrane material (BM). (D) Electron lucent lake (L) between the stroma (S) and Descemet’s membrane
(DM).
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reticulum and melanin granules (Fig 3D).
Other cell organelles were not well diVerenti-
ated.
KERATOCYTES
Degenerate keratocytes were observed in the
fibrotic pannus and in the PCL, and they were
also scattered throughout the stroma. Some of
the keratocytes in the fibrotic pannus were
rounded in shape (Fig 1F). In degenerate kera-
tocytes, the cytoplasm was either disintegrated
or had become a homogeneous mass, contain-
ing large vacuoles and melanin granules (Fig
3E). Nuclei were often apoptotic.
PROTEOGLYCANS
Proteoglycans (PG) in the basement mem-
branes and anterior stroma were abnormally
large (200–300 nm) (Fig 3F). Some aggregates
of these large PG filaments were observed just
below the basal epithelial cells where
hemidesmosomes were absent. In some re-
gions of the posterior stroma, PG were also
very large (180 nm). Large PG filaments were
also present around electron lucent lacunae
throughout the stroma. In the middle and, pos-
terior stroma and the PCL, PG filaments were
found in large quantities, but their size was
smaller (100 nm). A large quantity of abnor-
mal PG was observed at the endothelial face of
the PCL.
âIG-H3
In normal corneal samples, moderate labelling
was observed in the subepithelial basement
Figure 3 Electron micrographs of the posterior part of bullous keratopathy corneas. (A) Part of Descemet’s membrane
(DM) with a break (BR). (B) Collagen fibres (CF) and electron dense material in a break (BR) present in Descemet’s
membrane (DM). (C) Posterior collagenous layer (PCL) containing wide spacing collagen (LC) and microfilaments
(MF). (D) Below the PCL, an endothelial cell (EN) containing melanin granules (ML). (E) A degenerate keratocyte
(KR) containing melanin granules (ML). (F) Part of anterior stroma containing abnormal proteoglycans (PG).
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membrane, Bowman’s layer, and stroma.
Labelling was strong in patches of fibrillar
material near keratocytes but scanty around
the keratocytes themselves. Dense labelling
was seen in Descemet’s membrane, but not in
or close to the endothelium. Labelling was
absent from the epithelial cells and keratocytes.
In the BK specimens, a small amount of
labelling for âIG-H3 was observed in the
epithelial cells (Fig 4B), in the degenerate
Bowman’s layer, and in the normal looking
Bowman’s layer (Fig 4C). In some parts of
Bowman’s layer, labelling was dense. Labelling
was strong in the thick basement membrane,
especially around the disrupted anchoring fila-
ments (Fig 4D) and also within epithelial folds.
Below the basement membrane, fibrotic pan-
nus tissue was heavily labelled, while kerato-
cytes were not (Fig 4E, F) Labelling was mod-
erate in the anterior, middle, and posterior
stroma but there were also some more strongly
labelled patches. The electron dense material
around degenerate collagen fibrils (Fig 5A)
and the fibrillar material distributed through-
out the stroma was very strongly labelled with
the antibody (Fig 5B). Fibroblasts, keratocytes,
and lucent areas around keratocytes were not
labelled, but the fibrillar (or fibrous) material
(described earlier) adjacent to the keratocytes
was very strongly labelled with the antibody
(Fig 5C). Banded DM was heavily labelled
whereas homogeneous, non-banded DM was
Figure 4 Electron micrograph showing labelling of âig-h3 in BK corneas. (A) Control for immunoreaction. (B) Clumped
labelling in epithelial cell (E). (C) Moderate clumped labelling in normal looking Bowman’s layer (B). (D) Heavy
labelling in basement membrane (BM) and around disrupted anchoring filaments. (E) DiVuse labelling on fibrotic pannus
tissue (P) but not in the keratocyte (KR). (F) No labelling in the keratocyte but heavy labelling close to the keratocyte
(KR) in the anterior stroma (S).
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only moderately labelled (Fig 5D). In the PCL,
microfilaments, and basement membrane ma-
terial were heavily labelled (Fig 5E, F). Wide
spacing collagen and lucent spaces in the PCL
were not labelled. Endothelial cells, when
present, were not labelled, but the endothelial
face of the PCL had moderate labelling.
TENASCIN-C
Labelling of BC10 was seen in the squamous
(Fig 6A), wing, and basal epithelial cells.
Strong labelling was seen in electron lucent
spaces where the hemidesmosomes were ab-
sent and in the fibrotic pannus tissue, espe-
cially in the region where degenerate anchoring
filaments were seen (Fig 6B). DiVuse labelling
was observed in Bowman’s layer (Fig 6C) and
throughout the stroma (Fig 6D). Labelling was
very strong in the pre-Descemet’s stroma and
in the banded DM, especially close to the slit-
like lucent spaces (Fig 6E). The labelling was
also seen in the PCL (Fig 6F) and on the
endothelial face of the PCL.
A small amount of labelling TN2 of tenascin
was observed on the surface of the epithelium
and in epithelial cells. Some staining was seen
around degenerate keratocytes in the anterior
stroma. Clumped labelling was seen in the
fibrotic pannus tissue below the epithelium, in
the anterior stroma beneath Bowman’s layer,
and in the posterior stroma close to Descemet’s
membrane. No staining was seen in the middle
stroma or in the banded Descemet’s mem-
brane. Labelling was particularly high in the
Figure 5 Electron micrograph showing labelling of âig-h3 in BK corneas. (A) Labelling on electron dense material present
among collagen fibrils in the anterior stroma (S). (B) Labelling on fibrous (or fibrillar) material (FB) in the posterior
stroma (S). (C) Labelling on fine fibrous (or fibrillar) material (FB) close to degenerate keratocyte (KR) but not in the
keratocyte in the middle stroma (S). (D) Heavy labelling on banded Descemet’s membrane (BDM). (E) Labelling on
microfilaments (MF) in the PCL. (F) Labelling on electron dense material but not wide spacing collagen in the PCL.
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homogeneous middle and lower parts of the
non-banded DM and in the PCL.
FIBRILLIN
The labelling with fibrillin-1 clone MAB 2502
was observed on the very fine electron dense
fibrillar material both on the surface and within
the epithelial cells (Fig 7A). The labelling was
prominent in the pannus on fine microfila-
ments close to degenerate keratocytes (Fig 7B)
and in the anterior stroma (Fig 7C). Labelling
was also seen in DM and the PCL on very fine
microfibrils close to the endothelium. Label-
ling with fibrillin clone MAB 1919 was similar
to that with fibrillin-1 clone MAB 2502, but
was more intense, especially in DM (Fig 7D).
It was also observed in the middle and
posterior stroma.
FIBRONECTIN
Labelling for fibronectin was observed on the
surface of epithelial cells (Fig 7E) and within
the epithelial cells, close to the lucent spaces.
The labelling was also observed in the nucleus
and close to the nucleus and on the nuclear
membrane of the epithelial cells. The part of
the basement membrane that was attached to
the epithelial face was labelled with antibody,
and there was also some labelling in Bowman’s
layer. In the anterior, middle, and posterior
stroma, large portions of the longitudinally
running collagen fibrils were labelled with the
antibody (Fig 7F). The cytoplasm and nucleus
of the keratocytes in the stroma had prominent
labelling. The middle and endothelial faces of
DM and the fibrocellular layer also had
Figure 6 Electron micrographs of BK corneas showing labelling of BC10, in (A) epithelium (E), (B) Basement
membrane (BM) and around anchoring filaments (AC), (C) Bowman’s layer (B), (D) stroma (S), (E) banded
Descemet’s membrane (BDM), (F) posterior collagenous layer (PCL).
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electron dense patches labelled with the
antibody.
Discussion
In post-surgical bullous keratopathy, injury
causes a focal or diVuse disturbance of the
endothelium. Cell loss, where it occurs, is
followed by spreading of cells from the
adjacent areas of the endothelium. Where
endothelial loss is extreme, or where further
losses occur with the passage of time, the
resulting endothelial sheet may no longer be
able to perform its normal function of
deturgescing the cornea, and corneal oedema
results, with or without the formation of
epithelial bullae. Where the rate of endothelial
cell loss is so high that the remaining endothe-
lial cells are unable to cover the whole area of
the posterior cornea, the remaining endothelial
cells lose their normal appearance and func-
tion, and become flat or attenuated.6 This was
confirmed in the present study by LM and
TEM. The disordered endothelial sheet, per-
haps containing cells of fibroblastic origin, lays
down a posterior collagenous layer which may
be banded, fibrillar, or fibrocellular.
We have confirmed earlier observations that
endothelial damage causes nodulation, breaks,
and scroll formation in DM.6 Abnormal
endothelial function probably including fi-
broblastic activity, produces a posterior colla-
genous layer containing wide spacing collagen,
Figure 7 Electron micrograph of BK corneas showing labelling of fibrillin-1-MAB2502, fibrillin-MAB1919, and
fibronectin. (A) Fibrillin-1-MAB2502 labelling in epithelial cell (E), (B) diVuse labelling of fibrillin-1-MAB2502 on
microfibrils (F) near a degenerate keratocyte (KR) in the pannus (P). (C) fibrillin-MAB1919 labelling on collagen fibrils
in stroma (S), (D) Fibrillin-MAB1919 labelling on banded Descemet’s membrane (BDM). (E) Labelling of fibronectin
on the surface of the epithelium (E), and (F) in the stroma (S).
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microfilaments and basement membrane-like
material.7 The functional failure of the en-
dothelial cells leads to corneal oedema and for-
mation of bullae in the epithelium and subepi-
thelial region.
Endothelial decompensation leads to an
increase in stromal thickness and to subepithe-
lial fibrosis with an accumulation of abnormal
PG31 and degenerate collagen fibrils. It is
believed that the degenerate pannus is formed
when fibroblast-like cells, derived from the
corneal stroma, insinuate themselves into the
space between Bowman’s membrane and the
epithelial basement membrane.32 Keratocyte
numbers are reported to be reduced in bullous
keratopathy.6 Since the nutrition of keratocytes
would be anticipated to be relatively uninflu-
enced by the swelling, another mechanism
must be sought their loss. One suggested
mechanism is an involvement of the epithelium
in an IL-1, Fas/Fas ligand induced mechanism
of apoptotic death.33
Kenny et al 5 believe that the fibrotic pannus
is a response to the formation of epithelial bul-
lae. This is thought to lead to epithelial degen-
eration, reduplication, and the synthesis of an
intraepithelial basal lamina-like material,
within epithelial folds. Eagle et al32 suggested
that folded epithelial bullae are probably
caused by buckling of the basement membrane
due to a shift or dislocation of the loosened or
shallowly detached corneal epithelium. The
abnormal function of the epithelium produces
a multilayered basal lamina, and loss of
hemidesmosomes results in disruption of the
anchoring filaments.
Immunoelectron microscopy has shown for the
first time the precise labelling of proteins at the
cellular and subcellular level which could not be
shown by light microscopy or by any other tech-
nique. This ultrastructural localisation of the
proteins has provided us with a better under-
standing of their involvement in BK corneas:
âIG-H3
In our normal corneal samples, labelling was
observed in the subepithelial basement mem-
brane, Bowman’s layer, stroma, and De-
scemet’s membrane, but not in or close to the
endothelium. Similar labelling of âig-h3 was
observed by Streeten et al.34 Takács et al11
reported that, in normal cornea, labelling was
strong in the basal epithelial cell layer and
endothelium, faint in the stroma and kerato-
cytes, and absent in Bowman’s layer and DM.
This diVers from our findings in BK, where
labelling was scanty in the epithelial cells, and
heavy in the thick basement membrane, on the
anchoring filaments, in some parts of the
stroma and on the very fine fibrous material
around keratocytes. Labelling was not seen
within keratocytes. Absence of labelling in
keratocytes suggests that most of the âig-h3
protein has been secreted from the epithelium
and deposited on the fibrous material. Label-
ling was also strong on fibrous material in the
stroma, in DM, and on microfilaments in the
PCL but it was not seen in the endothelium.
Most of the stroma had moderate labelling.
Takács et al11 reported that in PBK, there was
positive labelling of the basal epithelial layer,
under the epithelium, in and above the
endothelium, and in the keratocytes, contrary
to our observations. They also found staining
in the fibrotic area—that is, the pannus and
PCL, similar to our findings.
The association of âig-h3 with extracellular
matrix macromolecules, such as fibrillin in
microfibrils,35 type II collagen in cartilage,36
and type VI collagen in cornea37 38 has sug-
gested that âig-h3 functions as an extracellular
matrix molecule, perhaps facilitating cell-
matrix interactions during morphogenesis.14 37
âig-h3 is found in rabbit corneal epithelial
cells,39 and both in the corneal epithelium and
endothelium, as well as in the newly formed
extracellular matrix of Fuchs’ dystrophy cor-
nea.40 It is likely that in the oedematous stroma
of BK, the distribution of âig-h3 across the
stroma is facilitated by the widening of
intercollagenous fibrillar spaces41.
The presence of TGF-â1, TGF-â2, and
cytokines (IFN-r, IL-2, IL-4, IL-10, IL-12)
was shown in bullous keratopathy corneas, and
scarring often accompanies this disease.42 Fur-
thermore, TGF-â, which has an important role
in wound healing, is considered to be the major
factor for enhancing the secretion of âig-h3.11
It is believed that TGF-â promotes the
secretion of âig-h3 in BK corneas. Since it has
been found in several cell types,14 42 it is
believed that this protein (âig-h3) could also
play an important part in cellular adhesion
and/or signalling11 21 like other proteins such as
TN-C and fibrillin.8 9 11
TENASCIN-C
From our observations, labelling of TNC by
TN-2 and BC10 was found in the fibrotic pan-
nus and PCL, anterior stroma and pre-
Descemet’s posterior stroma, and in non-
banded DM, similar to the observation of
Ljubimov et al.8 In addition, however, BC10
labelling was also found within epithelial cells,
in the basement membrane around disrupted
anchoring filaments, in Bowman’s layer, and in
banded DM close to electron lucent spaces.
Ljubimov et al8 have suggested that following
injury, mechanical stress on myofibroblasts
induced by stromal swelling, causes contrac-
tion which acts on the surrounding collagen
fibrils, and tends to compress the normal
structure of the stroma, which results in the
production and deposition of TNC.8 In
cultures, contraction of myofibroblasts induces
the production and deposition of TNC.16
Maseruka et al25 have also demonstrated
persistent TNC expression in corneas at sites
of tension in malapposed corneal grafts. TNC
variants have adhesive, as well as anti-adhesive
properties. Using the monoclonal antibody
BC2, which recognises high Mr TNC variants
associated (in vitro) with anti-adhesion and
proliferation, Maseruka et al9 demonstrated the
presence of anti-adhesive variants along the
borders of subepithelial bullae in pseudophakic
bullous keratopathy corneas. BC2 is ineVective
as an immunoreagent under the conditions of
our ultrastructural study (data not presented)
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presumably because of failure of penetration of
antibody into the LR white resin embedded
tissue. However, we have shown BC10 and
TN2, which recognise all TNC variants, to be
present in areas of loss of intercellular contacts
and downregulation of focal adhesion, suggest-
ing a role in weakening cell-substrate attach-
ment and promotion of cell detachment by loss
of intercellular contacts and downregulation of
focal adhesion.16 19 43 44 Thus subepithelial
TN-C weakens the subepithelial adhesion con-
tributing to the formation of bullae.41 Small pH
variations can modify the TN-C splicing
pattern.45 In addition, TNC expression can
also be induced by fibrogenic cytokines46–48
such as TGF-â, fibroblast growth factor and,
platelet derived growth-BB, all of which also
induce the formation of âig-h3.8
FIBRILLIN
In normal adult cornea, peripheral epithelial
basement membrane showed positive staining
for fibrillin-1, but little or no fibrillin-1 staining
was detected in the central basement mem-
brane.10 28 29 We found no staining for fibrillin
in our normal cornea.
In an earlier study of BK, fibrillin-1 was
expressed in the epithelial basement mem-
brane, the stroma, DM, the area of subepithe-
lial fibrosis and in the PCL.10 We confirmed
these results and found similar fibrillin-1 stain-
ing on very fine fibrils in BK cornea. But we
also found staining on the epithelial surface
and inside the epithelial cells.
Fibrillin-1 accumulation has been observed
during corneal wound healing.49 It was also
found with fibrotic extracellular matrix at
Bowman’s layer breaks in keratoconus cor-
neas.5 50 It is believed that fibrillin-1 accumula-
tion in BK cornea may be part of a fibrotic,
healing process occurring in these corneas,
related to the altered fluid balance and corneal
swelling.10 It is possible that growth factors and
cytokines, which are expressed during wound
healing, may contribute to the appearance of
fibrillin-1. An increased level of interleukins 1á
(IL-1á) and 8 (IL-á8) in BK cornea42 might be
responsible for the expression of fibrillin-1 as
was observed in UVB damaged skin.51
With endothelial failure, fluid accumulates in
the stroma and epithelium. This results in the
formation of stromal lakes or subepithelial and
intraepithelial bullae and causes mechanical
stress to cells in the neighbourhood of the fluid
accumulation. We suggest that this, in turn, may
induce epithelial cells, keratocytes, and fibro-
blasts in these aVected areas to produce TNC,
âig-h3, and fibrillin as part of an injury
response. It is likely that this occurs in response
to the release of growth factors and cytokines,
which enhance the production of the above pro-
teins.6 25 The induction of the production of
anti-adhesive TNC variants,5 together with
âig-h3 and fibrillin, contributes to the poor
adhesive and growth properties of the epithe-
lium.
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